How to Help Your Patients Save Money on Zoryve: A Provider's Guide to Savings Programs

Zoryve (roflumilast) has a retail price of $950–$1,145 per 60-gram tube. Without the right support programs in place, cost becomes the primary reason patients abandon this otherwise highly effective prescription. For dermatologists, PCPs, NPs, and PAs, knowing which savings tools exist — and how to activate them quickly — directly affects whether your patients actually use the treatment you've chosen for them.

This guide covers every Zoryve savings program available in 2026, how to help patients enroll, and practical strategies to minimize cost-related prescription abandonment.

Understanding the Cost Barrier

Prescription abandonment at the pharmacy counter is one of the most significant gaps between clinical intent and actual outcomes in specialty dermatology. Studies consistently show that when patients see a high copay or cash price, they often leave without the prescription — without calling your office, without asking for alternatives.

For Zoryve, the three most common cost scenarios are:

Commercially insured, prior auth approved: Patient owes specialty tier copay. Without savings card: $100–$300+. With ZORYVE Direct Savings Card: as little as $0.

Commercially insured, prior auth pending or denied: Patient pays full cash price ($950–$1,145) or goes without. Savings cards may still help if drug is not currently covered.

Uninsured or underinsured: Patient cannot afford cash price. Arcutis Cares PAP provides medication at no cost to eligible patients.

Program 1: ZORYVE Direct Savings Card

The ZORYVE Direct Savings Card is Arcutis Biotherapeutics' commercial insurance co-pay assistance program. It is the most powerful savings tool for the majority of your working-age patients.

Best for: Commercially insured patients with employer-sponsored or marketplace plans.

What it offers: Eligible patients may pay as little as $0 per fill, subject to eligibility criteria and maximum program limits.

Not valid for: Medicare, Medicaid, TRICARE, or other government programs; cash-paying patients.

Enrollment: Patients enroll at zoryve.com or by texting SAVE to 440-496-7983. Your office can also initiate enrollment.

Renewal: Renews annually on January 1. Remind patients to re-enroll each year.

Pro tip: If your practice has an Arcutis sales representative, ask them about in-office enrollment support. Some practices print savings card enrollment instructions directly on the prescription bag or patient visit summary.

Program 2: Arcutis Cares Patient Assistance Program (PAP)

The Arcutis Cares Patient Assistance Program provides Zoryve at no cost to financially eligible patients who are uninsured or underinsured. This is a critical resource for your most vulnerable patient population.

Best for: Uninsured patients, patients with Medicaid or Medicare Part D who cannot afford their medication, and underinsured patients whose plans don't cover Zoryve.

What it offers: Zoryve at no cost for up to 12 months to eligible patients.

Eligibility: U.S. residents who meet financial eligibility requirements and are prescribed Zoryve for an FDA-approved use. Your practice initiates the application with a physician signature.

How to apply: Download the enrollment form at arcutiscares.com. Complete it with the patient and fax to 855-237-9113. Or call 855-600-3755 (Mon–Fri, 8 AM–8 PM ET) for enrollment assistance.

ZORYVE Direct Hub: More Than a Savings Card

Beyond the savings card, the ZORYVE Direct hub program offers services that can significantly reduce the administrative burden on your practice:

Prescription status tracking and patient communication

Refill reminders sent directly to patients via text

Pharmacy routing guidance to ensure patients go to pharmacies that stock Zoryve

Benefits investigation support to identify insurance coverage status upfront

38,004+ patients found their medications in stock

38K+

Find Zoryve In Stock Today →

Prior Authorization: Maximizing Approval Rates

A PA approval is the first step to getting insurance to cover Zoryve. Submission quality directly affects approval rates. Best practices:

Submit the PA the same day as the prescription — don't wait for the patient to call back.

Include ICD-10 codes for the specific diagnosis (e.g., L40.0 for plaque psoriasis, L20.89 for atopic dermatitis).

Document prior therapy. Include specific agents tried, duration, and reason for failure or discontinuation.

Document steroid contraindication when relevant. Psoriasis on the face, genitals, or intertriginous areas — note explicitly why steroid alternatives are not appropriate.

Cite AAD guidelines. The AAD's 2025 guidelines strongly recommend Zoryve cream 0.15% for adults with mild to moderate atopic dermatitis — reference this for eczema PAs.

Appeal denials promptly. Request a peer-to-peer review within 24–48 hours of denial. Most denials are overturned at the peer-to-peer level with strong clinical documentation.

Cost-Savings Conversation: What to Say to Your Patients

Many patients won't bring up cost concerns unless you raise the topic first. Incorporating a brief cost conversation into your prescribing routine can prevent silent abandonment:

Suggested script: "This medication can be expensive without the right support. There's a savings card from the manufacturer that can bring the cost down significantly if you have commercial insurance. If you're uninsured or cost is a barrier, there's also a patient assistance program that provides it at no cost. Here's the information — do you want me to have my staff help you enroll before you leave today?"

Skip the calls, skip the stress.

Find Zoryve In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Help Patients Find Zoryve at a Pharmacy

Even after a PA approval and savings card enrollment, patients may still struggle to find a pharmacy that has Zoryve in stock. medfinder can help — it's a service that calls pharmacies near your patient's location to find which ones can fill their specific Zoryve prescription, and texts them the results. Learn more at medfinder.com/providers, or see our companion guide: How to Help Your Patients Find Zoryve in Stock.